VIE/BMRN (VIE/BMRN)

Vienna Stock Exchange: VIE/BMRN · EUR

€51.2

+1.16 (+2.3%)· Recorded snapshot

Market cap	10B
Revenue (ttm)	3B
Net income (ttm)	63.9M
EPS (ttm)	€0.34
P/E (trailing)	150.4x
P/E (forward)	11.5x
Volume	566

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): 63.9M
EPS (ttm): €0.34
P/E (trailing): 150.4x
P/E (forward): 11.5x
Market cap: 10B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.5

P25 14.3P50 18.7P75 25.4

Trailing P/E150.4

P25 20.4P50 26.7P75 39.7

ROE1.2

P25 4.8P50 10.6P75 20.1

ROIC3.2

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/BMRN indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-02
Employees	3,221
Employees change	-361
Employees growth	-10.61%
Enterprise value	EUR 12.9B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Biotechnology
Is primary listing	No
ISIN number	US09061G1013
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 10B
Next earnings date	2026-11-02
Price	EUR 51.18
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/BMRN
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	135.19x
Average P/E ratio (3Y)	60.01x
Average P/E ratio (5Y)	157.57x
Earnings yield	0.66%
EV/Earnings	199.02x
EV/EBIT	28.35x
EV/EBITDA	21.62x
EV/FCF	19.67x
EV/Sales	4.16x
FCF / EV yield	5.08%
FCF yield	6.64%
Forward P/E	11.46x
Graham number	14.50317
Graham upside	-71.01%
Lynch fair value	EUR 1.64
Lynch upside	-96.72%
P/(FCF - SBC) ratio	21.25x
P/(OCF - SBC) ratio	17.31x
P/B ratio	1.76x
P/E ratio	150.43x
P/FCF ratio	15.05x
P/OCF ratio	12.96x
P/S ratio	3.26x
Price / tangible book value	14.13x
Price/EBITDA ratio	17.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.67%
EBITDA margin	18.94%
Effective tax rate	51.06%
FCF margin	21.13%
Gross margin	50.97%
Operating margin	14.67%
Pretax margin	4.38%
Profit margin	2.14%
Profit per employee	EUR 19,830
Profitable quarters	2
Profitable years	4
Revenue per employee	EUR 925,740
ROA	3.26%
ROA (5Y)	2.28%
ROCE	4.97%
ROE	1.18%
ROE (5Y)	3.83%
ROIC	3.24%
ROIC (5Y)	3.88%
SBC / revenue	6.32%
Tax / revenue	2.24%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-88.85%
EPS growth (Q)	-81.3%
EPS growth (QoQ)	-57.65%
EPS growth 3Y	-10.29%
EPS growth 5Y	-38.77%
EPS growth years	0
FCF growth	6.23%
FCF growth (Q)	-17.17%
FCF growth (QoQ)	-30.26%
FCF growth 3Y	144.98%
FCF growth 5Y	33.6%
Gross profit growth	-1.29%
Gross profit growth (Q)	15.11%
Gross profit growth 3Y	18.44%
Gross profit growth 5Y	18.57%
Net income growth	-88.9%
Net income growth (Q)	-81.39%
Net income growth (QoQ)	-57.58%
Net income growth 3Y	-9.97%
Net income growth 5Y	-38.61%
Net income growth years	0
OCF growth	11.78%
OCF growth (Q)	-9.26%
OCF growth (QoQ)	-23.81%
OCF growth 3Y	74.52%
OCF growth 5Y	26.07%
Operating income growth	-35.61%
Operating income growth (Q)	-24.36%
Operating income growth 3Y	58.48%
Revenue growth	11.2%
Revenue growth (Q)	19.91%
Revenue growth (QoQ)	29.17%
Revenue growth 10Y	13.34%
Revenue growth 3Y	15.09%
Revenue growth 5Y	12.19%
Revenue growth quarters	18
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -104.1M
Depreciation and amortization	EUR 130.7M
EBIT	EUR 437.4M
EBITDA	EUR 564.8M
EPS	EUR 0.34
Financing cash flow	EUR 3.1B
Free cash flow	EUR 646.1M
Free cash flow minus SBC	EUR 457.7M
Gross profit	EUR 1.5B
Income taxes	EUR 66.6M
Investing cash flow	EUR -4.2B
Net borrowing	EUR 3.3B
Net cash flow	EUR -297.4M
Net income	EUR 63.9M
Operating cash flow minus SBC	EUR 561.7M
Operating income	EUR 437.4M
Revenue	EUR 3B
Stock-based compensation	EUR 188.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.9
Book value per share	EUR 28.59
Debt / EBITDA	6.41
Debt / equity	0.66
Debt / FCF	5.69
Goodwill	EUR 588.7M
Interest coverage	5.98
Long-term assets	EUR 6.7B
Long-term liabilities	EUR 3.2B
Net cash (debt)	EUR -2.9B
Net cash / market cap	-29.95%
Net debt / EBITDA	5.16
Net debt / equity	0.53
Net debt / FCF	4.51
Piotroski F-Score	4
Property, plant and equipment	EUR 888.7M
Shareholders' equity	EUR 5.5B
Tangible book value	EUR 688.5M
Tangible book value per share	EUR 3.56
Total assets	EUR 10.3B
Total cash	EUR 765M
Total debt	EUR 3.7B
Total liabilities	EUR 4.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	EUR 3.6B
Current liabilities	EUR 1.5B
Current ratio	2.39
Inventory turnover	1.07
Net working capital	EUR 1.8B
Quick ratio	1.16
Working capital	EUR 2B
Working capital turnover	1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.61%
Shareholder yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 50.86
1D price change	2.32%
1M price change	-6.29%
1M total return	-6.29%
1W price change	0.5%
1W total return	0.5%
1Y price change	6.22%
1Y return CAGR	6.23%
1Y total return	6.22%
20-day SMA	EUR 50.11
200-day SMA	EUR 50.57
3M price change	-6.54%
3M total return	-6.54%
3Y price change	-34.22%
3Y return CAGR	-13.03%
3Y total return	-34.22%
50-day SMA	EUR 53.72
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 61.40
52-week high date	2026-08-13
52-week low	EUR 42.77
52-week low date	2026-05-20
5Y price change	-20.2%
5Y return CAGR	-4.41%
5Y total return	-20.2%
6M price change	8.79%
6M total return	8.79%
All-time high	EUR 115.02
All-time high date	2020-07-20
All-time low	EUR 42.77
All-time low date	2026-05-20
Average true range (ATR)	EUR 1.11
Average volume	48.1
Change from 52-week high	-16.64%
Change from 52-week low	19.66%
Change from all-time high	-56.51%
Change from all-time low	16.95%
Change from open	1.51%
Day's gap	0.8%
Dollar volume	EUR 28,968
High price	EUR 51.18
Low price	EUR 49.40
Monthly RSI	43.59
Open price	EUR 50.42
Position in 52-week range	100%
Previous close	EUR 50.02
Price vs 150-day SMA	-1.66%
Price vs 20-day SMA	-0.17%
Price vs 200-day SMA	-1.09%
Price vs 50-day SMA	-6.89%
Relative volume	11.78
RSI	44.17
Sharpe ratio	0.26
Sharpe ratio (3Y)	-0.39
Sharpe ratio (5Y)	-0.18
Sortino ratio	0.63
Sortino ratio (3Y)	-0.38
Sortino ratio (5Y)	-0.08
Volume	566
Weekly RSI	45.27
YTD price change	-1.73%
YTD total return	-1.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192.6M
Shares change (QoQ)	-1.62%
Shares change (YoY)	0.61%
Shares held by insiders	0.4%
Shares held by institutions	102.68%
Short ratio	5.4 days

Deeper analysis on VIE/BMRN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/BMRN report

Is a complete VIE/BMRN research report available?

No complete published report is available for vie/BMRN (VIE/BMRN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/BMRN (VIE/BMRN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BMRN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/BMRN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BMRN

Frequently asked questions